Effects of ρ‐Da1a a peptidic α1A‐adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2012.02231.xPMID 23005263PMCID PMC3579283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.

  2012cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the α1A‐adrenoceptor

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Rapid efficacy of the highly selective α(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

  2009cited by this paper
• Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

  2009cited by this paper
• Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery.

  2009cited by this paper
• Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors

  2009cited by this paper
• The α1A‐adrenoceptor gene is required for the α1L‐adrenoceptor‐mediated response in isolated preparations of the mouse prostate

  2008cited by this paper
• Identification of α1L‐adrenoceptor in mice and its abolition by α1A‐adrenoceptor gene knockout

  2008cited by this paper
• ALFUZOSIN REVERSES BLADDER OVERACTIVITY INDUCED BY CYCLOPHOSPHAMIDE IN CONSCIOUS RATS

  2008cited by this paper
• Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study

  2007cited by this paper
• The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract.

  2007cited by this paper
• Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association?

  2006cited by this paper
• Intraoperative floppy-iris syndrome associated with tamsulosin.

  2006cited by this paper
• Intraoperative floppy iris syndrome associated with tamsulosin

  2005cited by this paper
• The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.

  2005cited by this paper
• Recent advances in alpha1-adrenoceptor pharmacology.

  2004cited by this paper
• A Pharmacology Primer: Theory, Application and Methods

  2004cited by this paper
• Recent advances in alpha1-adrenoceptor pharmacology.

  2003cited by this paper
• Recent advances in α1-adrenoceptor pharmacology

  2003cited by this paper
• Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate.

  2002influential reference
• Tamsulosin: an overview

  2002cited by this paper
• Characterization of some novel α1-adrenoceptor antagonists in human hyperplastic prostate

  2002influential reference
• Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin.

  2001influential reference
• Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter

  2001cited by this paper
• An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.

  2000cited by this paper
• An Investigation of the Uroselective Properties of Four Novel α1a-Adrenergic Receptor Subtype-Selective Antagonists

  2000influential reference
• KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

  1999cited by this paper
• Contulakin-G, an O-Glycosylated Invertebrate Neurotensin*

  1999cited by this paper
• The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.

  1997cited by this paper
• Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group.

  1997influential reference
• The effects of tamsulosin, a high affinity antagonist at functional α1A‐ and α1D‐adrenoceptor subtypes

  1997cited by this paper
• The α-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate

  1996influential reference
• The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.

  1996influential reference
• Isolation of Lys-conopressin-G from the venom of the worm-hunting snail, Conus imperialis.

  1994cited by this paper
• Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.

  1993cited by this paper
• Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis.

  1988cited by this paper

• Orphan Three-Finger Toxins from Snake Venoms: Unexplored Library of Novel Biological Ligands with Potential New Structures and Functions

  2025cites this paper
• Cardiac Profile in Patients with Snake Envenomation and Its Complications: A Retrospective Study from a Tertiary Care Center in South India

  2024cites this paper
• Structural and Functional Diversity of Animal Toxins Interacting With GPCRs

  2022influential citation
• Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection

  2021cites this paper
• Nature-derived peptides: a growing niche for GPCR ligand discovery

  2019cites this paper
• Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease

  2017cites this paper
• Polypharmacology profiles and phylogenetic analysis of three-finger toxins from mamba venom: case of aminergic toxins.

  2014cites this paper
• Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α1A-Adrenoceptor

  2013cites this paper